U.S. Markets open in 6 hrs 35 mins

Alere Inc. (ALR)


NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
50.45+0.03 (+0.06%)
At close: 4:02PM EDT
People also watch
BIOHAEPODDHOLXCRL
Full screen
Previous Close50.42
Open50.45
Bid0.00 x
Ask0.00 x
Day's Range50.43 - 50.49
52 Week Range31.47 - 50.55
Volume489,196
Avg. Volume1,679,661
Market Cap4.41B
Beta-0.65
PE Ratio (TTM)-20.20
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Market Realist13 hours ago

    What Were Abbott’s Key Growth Drivers for 2Q17?

    Abbott completed the acquisition of St. Jude Medical in January 2017. It contributed significantly to its 2Q17 sales.

  • American City Business Journalsyesterday

    Abbott deal will cost Alere three business units — and untold employees

    When it completes its $5.3 billion acquisition of Waltham-based Alere later this year, Abbott Laboratories will be getting one of the world’s largest makers of point-of-care diagnostic tests, a fast-growing sector. Thanks to antitrust rules, though, Abbott (ABT) will be taking on a slimmed-down version of Alere (ALR) by the end of September. Back in January, Illinois-based Abbott agreed to divest three Alere business units that make competing products in order to secure the approval of European Union antitrust regulators.

  • TheStreet.com6 days ago

    Abbott CEO: Another Alere-Related Divestiture Coming Soon

    Abbott CEO Miles White said on an earnings call the company will make one more asset sale as part of efforts to gain regulatory approval for the Abbott-Alere deal.